ORBIMED ADVISORS LLC: RNAM position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on RNAM, newest first. How the timeline and the estimate are built.
ORBIMED ADVISORS LLC held 0 RNAM shares at 2026-03-31 per its 13F-HR filed 2026-05-15.
the latest 13F is the newest step
- period ended2026-03-3113F 0 sharesChange vs previous 13F -619,530 shares
13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-12-3113F 619,530 sharesChange vs previous 13F -1,019,356 shares
0.91% of the 13F portfolio, value $44,686,699.
13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 1,638,886 sharesChange vs previous 13F -174,000 shares
1.71% of the 13F portfolio, value $71,406,263.
13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 1,812,886 sharesChange vs previous 13F 0 shares
1.29% of the 13F portfolio, value $51,485,962.
13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 1,812,886 sharesChange vs previous 13F +700,000 shares
1.29% of the 13F portfolio, value $53,516,395.
13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 1,112,886 sharesChange vs previous 13F +68,081 shares
0.67% of the 13F portfolio, value $32,362,725.
13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 1,044,805 sharesChange vs previous 13F not available
0.88% of the 13F portfolio, value $47,987,894.
13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).